Lineage Cell Therapeutics, Inc. ( LCTX) - Key Metrics
LCTX Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $0.03 | $0 | -$0.02 | -$0.02 |
| 2025Q3 | $0.02 | -$0.13 | -$0.02 | -$0.02 |
| 2025Q2 | $0.01 | -$0.13 | -$0.02 | -$0.02 |
| 2025Q1 | $0.01 | -$0.02 | -$0.02 | -$0.02 |
LCTX Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | 112.89 |
| 2025Q3 | ? | -3.25 |
| 2025Q2 | ? | -1.70 |
| 2025Q1 | ? | -6.17 |
LCTX Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q1 | -2.10% | ? |
| 2025Q4 | -1.30% | ? |
| 2025Q3 | -0.94% | ? |
| 2025Q2 | -2.68% | ? |
| 2025Q1 | -4.88% | ? |
LCTX
Price: $1.20
52 week price:
Payout Ratio Range:
Earnings Per Share: -0.29 USD
Exchange: ASE
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 400600
Market Capitalization: 311.6 million